CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Insys Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Insys Therapeutics Inc
3100 West Ray Road
Suite 201
Phone: (602) 910-2617p:602 910-2617 Chandler, AZ  85226  United States Fax: (302) 655-5049f:302 655-5049
This company's Plan of Liquidation went into effect on 2/18/2020
This company ceased filing statements with the SEC on 2/11/2020.
This company is no longer actively traded on any major stock exchange.
Business Summary
Insys Therapeutics, Inc., also known as Neopharm, Inc., is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid analgesic, for transmucosal absorption underneath the tongue. The Company markets Subsys through its field sales force focused on supportive care physicians in the United States.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/201912/31/2018YesYesYes-Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer AndreceHousley 51 4/14/2019 4/14/2019
Chief Scientific Officer Venkat R.Goskonda 4/15/2019
Director John A.McKenna 51 5/22/2019 5/22/2019
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Insys Manufacturing, LLC 3100 West Ray Road Chandler AZ United States
Insys Pharma Inc 3100 West Ray Road Chandler AZ United States

Business Names
Business Name
IC Operations, LLC
INSY
INSYQ
7 additional Business Names available in full report.

General Information
Outstanding Shares: 74,569,163 (As of 5/6/2019)
Shareholders: 35
Stock Exchange: OTC
Federal Tax Id: 510327886
Fax Number: (302) 655-5049


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023